This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jureen, P.
Right arrow Articles by Hoffner, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jureen, P.
Right arrow Articles by Hoffner, S. E.

Next Article 

Journal of Clinical Microbiology, June 2006, p. 1925-1929, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.02210-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis by Pyrosequencing Technology

Pontus Jureen,1,2* Lars Engstrand,1,2 Solveig Eriksson,1 Anders Alderborn,3 Margareta Krabbe,4 and Sven E. Hoffner2

Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm,1 Department of Bacteriology, Swedish Institute for Infectious Disease Control, Stockholm,2 Department of Genetics and Pathology, Uppsala University,3 Biology Education Center, Uppsala University, Uppsala, Sweden4

Received 20 October 2005/ Returned for modification 10 March 2006/ Accepted 26 March 2006

We developed an assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis based on Pyrosequencing technology, involving a technique for real-time sequencing. A 180-bp region of the rpoB gene was amplified in clinical isolates of both rifampin-resistant and -susceptible M. tuberculosis. The PCR products were subjected to Pyrosequencing analysis using four different sequencing primers in four overlapping reactions. These four sequencing reactions covered the 81-bp region where >96% of the mutations associated with rifampin resistance are located. The results were compared to those obtained with two other molecular methods, the line probe assay and cycle sequencing, and the phenotypic BACTEC method. The genotypic determination methods all detected the mutations that previously have been correlated with rifampin resistance. In addition, Pyrosequencing analysis and the two other molecular methods found additional mutations within the rpoB gene in phenotypically susceptible strains. We found that Pyrosequencing technology, in particular, offers high accuracy, short turnaround time, and a potentially high throughput in detection of rifampin resistance in M. tuberculosis.

* Corresponding author. Mailing address: Department of Bacteriology, Swedish Institute for Infectious Disease Control, SE-17182 Solna, Sweden. Phone: 46 8 457 2473. Fax: 46 8 301797. E-mail: pontus.jureen{at}smi.ki.se.

Journal of Clinical Microbiology, June 2006, p. 1925-1929, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.02210-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Thulin, S., Olcen, P., Fredlund, H., Unemo, M. (2008). Combined Real-Time PCR and Pyrosequencing Strategy for Objective, Sensitive, Specific, and High-Throughput Identification of Reduced Susceptibility to Penicillins in Neisseria meningitidis. Antimicrob. Agents Chemother. 52: 753-756 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»